Kwang-Seok Oh

Dr. Kwang-Seok Oh

orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 October 2020 in Bioinformatics
Verified
Journal Article
Closed access
BSBilal Shaker
Bilal Shaker
MYMyeong-Sang Yu
Myeong-Sang Yu
JSJin Sook Song
Jin Sook Song
SASunjoo Ahn
Sunjoo Ahn
JRJae Yong Ryu
Jae Yong Ryu
DNDokyun Na
Dokyun Na
Motivation: Identification of blood–brain barrier (BBB) permeability of a compound is a major challenge in neurotherapeutic drug discovery. Conventional approaches for BBB permeability measurement are expensive, time-consuming and labor-intensive. BBB permeability is associated with diverse chemical properties of compounds. However, BBB permeability prediction models have been developed using small datasets and limited features, which are usually not practical due to their low coverage of chemical diversity of compounds. Aim of this study is to develop a BBB permeability prediction model using a large dataset for practical applications. This model can be used for facilitated compound screening in the early stage of brain drug discovery. Results: A dataset of 7162 compounds with BBB permeability (5453 BBB+ and 1709 BBB-) was compiled from the literature, where BBB+ and BBB- denote BBB-permeable and non-permeable compounds, respectively. We trained a machine learning model based on Light Gradient Boosting Machine (LightGBM) algorithm and achieved an overall accuracy of 89%, an area under the curve (AUC) of 0.93, specificity of 0.77 and sensitivity of 0.93, when 10-fold cross-validation was performed. The model was further evaluated using 74 central nerve system compounds (39 BBB+ and 35 BBB-) obtained from the literature and showed an accuracy of 90%, sensitivity of 0.85 and specificity of 0.94. Our model outperforms over existing BBB permeability prediction models. Availabilityand implementation: The prediction server is available at http://ssbio.cau.ac.kr/software/bbb.

29 May 2019 in BMC Bioinformatics
Verified
Journal Article
Open access
PDF file
HLHyang-Mi Lee
Hyang-Mi Lee
MYMyeong-Sang Yu
Myeong-Sang Yu
SKSayada Reemsha Kazmi
Sayada Reemsha Kazmi
SOSeong Yun Oh
Seong Yun Oh
KRKi-Hyeong Rhee
Ki-Hyeong Rhee
DNDokyun Na
Dokyun Na
Drug candidates often cause an unwanted blockage of the potassium ion channel of the human ether-a-go-go-related gene (hERG). The blockage leads to long QT syndrome (LQTS), which is a severe life-threatening cardiac side effect. Therefore, a virtual screening method to predict drug-induced hERG-related cardiotoxicity could facilitate drug discovery by filtering out toxic drug candidates. In this study, we generated a reliable hERG-related cardiotoxicity dataset composed of 2130 compounds, which were carried out under constant conditions. Based on our dataset, we developed a computational hERG-related cardiotoxicity prediction model. The neural network model achieved an area under the receiver operating characteristic curve (AUC) of 0.764, with an accuracy of 90.1%, a Matthews correlation coefficient (MCC) of 0.368, a sensitivity of 0.321, and a specificity of 0.967, when ten-fold cross-validation was performed. The model was further evaluated using ten drug compounds tested on guinea pigs and showed an accuracy of 80.0%, an MCC of 0.655, a sensitivity of 0.600, and a specificity of 1.000, which were better than the performances of existing hERG-toxicity prediction models. The neural network model can predict hERG-related cardiotoxicity of chemical compounds with a high accuracy. Therefore, the model can be applied to virtual high-throughput screening for drug candidates that do not cause cardiotoxicity. The prediction tool is available as a web-tool at http://ssbio.cau.ac.kr/CardPred .

5 February 2020 in Bioinformatics
Verified
Journal Article
Closed access
JRJae Yong Ryu
Jae Yong Ryu
MLMi Young Lee
Mi Young Lee
JLJeong Hyun Lee
Jeong Hyun Lee
BLByung Ho Lee
Byung Ho Lee
KOKwang-Seok Oh
Kwang-Seok Oh
Motivation: Blockade of the human ether-à-go-go-related gene (hERG) channel by small compounds causes a prolonged QT interval that can lead to severe cardiotoxicity and is a major cause of the many failures in drug development. Thus, evaluating the hERG-blocking activity of small compounds is important for successful drug development. To this end, various computational prediction tools have been developed, but their prediction performances in terms of sensitivity and negative predictive value (NPV) need to be improved to reduce false negative predictions. Results: We propose a computational framework, DeepHIT, which predicts hERG blockers and non-blockers for input compounds. For the development of DeepHIT, we generated a large-scale gold-standard dataset, which includes 6632 hERG blockers and 7808 hERG non-blockers. DeepHIT is designed to contain three deep learning models to improve sensitivity and NPV, which, in turn, produce fewer false negative predictions. DeepHIT outperforms currently available tools in terms of accuracy (0.773), MCC (0.476), sensitivity (0.833) and NPV (0.643) on an external test dataset. We also developed an in silico chemical transformation module that generates virtual compounds from a seed compound, based on the known chemical transformation patterns. As a proof-of-concept study, we identified novel urotensin II receptor (UT) antagonists without hERG-blocking activity derived from a seed compound of a previously reported UT antagonist (KR-36676) with a strong hERG-blocking activity. In summary, DeepHIT will serve as a useful tool to predict hERG-induced cardiotoxicity of small compounds in the early stages of drug discovery and development. Availability and implementation: https://bitbucket.org/krictai/deephit and https://bitbucket.org/krictai/chemtrans Supplementary information: Supplementary data are available at Bioinformatics online.

15 September 2023 in Bioinformatics
Verified
Journal Article
Open access
PDF file
BSBilal Shaker
Bilal Shaker
JLJingyu Lee
Jingyu Lee
YLYunhyeok Lee
Yunhyeok Lee
MYMyeong-Sang Yu
Myeong-Sang Yu
HLHyang-Mi Lee
Hyang-Mi Lee
DNDokyun Na
Dokyun Na
Efficient assessment of the blood–brain barrier (BBB) penetration ability of a drug compound is one of the major hurdles in central nervous system drug discovery since experimental methods are costly and time-consuming. To advance and elevate the success rate of neurotherapeutic drug discovery, it is essential to develop an accurate computational quantitative model to determine the absolute logBB value (a logarithmic ratio of the concentration of a drug in the brain to its concentration in the blood) of a drug candidate. Here, we developed a quantitative model (LogBB_Pred) capable of predicting a logBB value of a query compound. The model achieved an R2 of 0.61 on an independent test dataset and outperformed other publicly available quantitative models. When compared with the available qualitative (classification) models that only classified whether a compound is BBB-permeable or not, our model achieved the same accuracy (0.85) with the best qualitative model and far-outperformed other qualitative models (accuracies between 0.64 and 0.70). For further evaluation, our model, quantitative models, and the qualitative models were evaluated on a real-world central nervous system drug screening library. Our model showed an accuracy of 0.97 while the other models showed an accuracy in the range of 0.29–0.83. Consequently, our model can accurately classify BBB-permeable compounds as well as predict the absolute logBB values of drug candidates. Web server is freely available on the web at http://ssbio.cau.ac.kr/software/logbb_pred/. The data used in this study are available to download at http://ssbio.cau.ac.kr/software/logbb_pred/dataset.zip.

1 November 2011 in International Immunopharmacology
Verified
Journal Article
Closed access
KOKwang-Seok Oh
Kwang-Seok Oh
BOByung Koo Oh
Byung Koo Oh
JMJihye Mun
Jihye Mun
HSHo Won Seo
Ho Won Seo
BLByung Ho Lee
Byung Ho Lee

1 March 2009 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
KOKwang-Seok Oh
Kwang-Seok Oh
SRShi Yong Ryu
Shi Yong Ryu
SLSunghou Lee
Sunghou Lee
HSHo Won Seo
Ho Won Seo
BOByung Koo Oh
Byung Koo Oh
BLByung Ho Lee
Byung Ho Lee